Log in

Relevant bibliographies by topics / Patented drugs / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Patented drugs.

Dissertations / Theses on the topic 'Patented drugs'

Author: Grafiati

Published: 28 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Patented drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Figueiredo, Luciano Lima. "A função social das patentes de medicamentos." Universidade Federal da Bahia, 2008. http://www.repositorio.ufba.br/ri/handle/ri/12373.

Full text

Abstract:

248 f.<br>Submitted by Ana Valéria de Jesus Moura (anavaleria_131@hotmail.com) on 2013-07-31T14:26:22Z No. of bitstreams: 1 LUCIANO LIMA FIGUEIREDO.pdf: 1277407 bytes, checksum: 4a9e492e2ca9afe642e59c6fa5a8d6d0 (MD5)<br>Approved for entry into archive by Ana Valéria de Jesus Moura(anavaleria_131@hotmail.com) on 2013-07-31T14:28:27Z (GMT) No. of bitstreams: 1 LUCIANO LIMA FIGUEIREDO.pdf: 1277407 bytes, checksum: 4a9e492e2ca9afe642e59c6fa5a8d6d0 (MD5)<br>Made available in DSpace on 2013-07-31T14:28:27Z (GMT). No. of bitstreams: 1 LUCIANO LIMA FIGUEIREDO.pdf: 1277407 bytes, checksum: 4a9e492e

APA, Harvard, Vancouver, ISO, and other styles

2

Грабовська, О. В. "Економічний аналіз міжнародного та національного ринку фармацевтичної продукції". Master's thesis, Сумський державний університет, 2018. http://essuir.sumdu.edu.ua/handle/123456789/71513.

Full text

Abstract:

Магістерська робота присвячена аналізу глобального та українського ринку фармацевтичної продукції. Вона аналізує поточну ситуацію на ринку, ризики та переваги, основні рушійні сили та основних гравців на ринку. Головна мета цього дослідження — провести аналіз ринку для міжнародної компанії.<br>The master’s thesis focuses on the analysis of the global and Ukrainian market of pharmaceutical products. It examines the current situation on the market, its risks and benefits, the main driving forces and the main players on the market. The main aim of this study is to conduct the market analysis for

APA, Harvard, Vancouver, ISO, and other styles

3

Harnisch, Sandy. "Die Zwangslizenz im südafrikanischen und deutschen Patentrecht : ein Rechtsvergleich unter besonderer Berücksichtigung der Arzneimittelerfindungen /." Berlin : BWV, Berliner Wiss.-Verl, 2006. http://deposit.ddb.de/cgi-bin/dokserv?id=2792408&prov=M&dok_var=1&dok_ext=htm.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

袁慶文. "基於引證網絡的藥品專利價值分析". Thesis, University of Macau, 2018. http://umaclib3.umac.mo/record=b3952162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

胡元佳. "Pharmaceutical patent valuation based on technology innovation and applications in the industry." Thesis, University of Macau, 2009. http://umaclib3.umac.mo/record=b2150641.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Oliveira, Carlos Fernando Lopes de. "Patentes de fármacos: as tensões existentes entre os interesses da indústria farmacêutica e as necessidades das populações." Universidade Federal da Paraíba, 2010. http://tede.biblioteca.ufpb.br:8080/handle/tede/4363.

Full text

Abstract:

Made available in DSpace on 2015-05-07T14:27:05Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 2044681 bytes, checksum: 09d18643545c26dd327be8c0d35cd1d2 (MD5) Previous issue date: 2010-04-27<br>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior<br>It is a study focused on the medicament patent from the analysis of the existing tensions among the pharmaceutical industry and the population necessities regarding medicine access. It is well-known the inner nature of the fundamental rights the condition of its social function. In this context, reasoning regarding the protection limits co

APA, Harvard, Vancouver, ISO, and other styles

7

Rigestam, Björn. "Pharmaceutical patents and generic drugs : When may interim injunctions be issued against an attempt or preparation to offer generic drugs on the market?" Thesis, Internationella Handelshögskolan, Högskolan i Jönköping, IHH, Rättsvetenskap, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-18933.

Full text

Abstract:

Since the implementation of Directive 2004/48 EC on the Enforcement of Intellectual Property Rights in Sweden there is today a possibility for pharmaceutical companies holding a patent to issue interim injunctions against a generic company on the grounds of an attempt or preparation to a pharmaceutical patent infringement. It has been shown that one of the earliest steps in which a generic company may infringe a pharmaceutical patent is to offer the generic drugs onto the market. However, since the implementation of the attempt and preparation rule in the Swedish Patent Act questions have been

APA, Harvard, Vancouver, ISO, and other styles

8

譚偉民. "活血化瘀中成藥處方和製備工藝改進 : 雲南白藥劑型的質量比較分析". HKBU Institutional Repository, 2010. http://repository.hkbu.edu.hk/etd_ra/1132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Vargas, Chaves Iván Guillermo. "Balances, realidades y perspectivas de las patentes farmacéuticas." Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/664063.

Full text

Abstract:

Esta investigación explora la evolución de la patente farmacéutica en España desde su ordenamiento jurídico interno; el régimen aplicable en el Derecho comunitario europeo; y en el comercio internacional. Se realiza, siguiendo esta línea histórica, una aproximación crítica sobre la necesidad de repensar el equilibrio que debe existir entre la exclusividad que otorga la patente a sus titulares, y un acceso a los medicamentos en igualdad de condiciones. La investigación además sustenta, entre otras cuestiones relevantes en el panorama legislativo y jurisprudencial evolutivo, el contexto en el qu

APA, Harvard, Vancouver, ISO, and other styles

10

Chan, Yuen Cheung. "Quality evaluation and anti-chronic glomerulonephritis properties of a patent herbal drug yi-shen-hua-shi granule." HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/825.

Full text

Abstract:

Yi-Shen-Hua-Shi (YSHS) granule is a Chinese patent drug for treating chronic glomerulonephritis (CGN). It was marketed in 2009. However, up to now, there is no report about the quality and pharmacological activities of this product. In this work，we evaluated the quality and anti-CGN effects of the drug. To evaluate the quality of the granule, a qualitative and quantitative HPLC-DAD analytical method was developed. For qualitative analysis, HPLC fingerprint of ten batches of YSHS granule was established. The fingerprints were analyzed using similarity evaluation, hierarchical cluster analysis (

APA, Harvard, Vancouver, ISO, and other styles

11

Chandratre, Chaitanya. "Medicare drug plan formulary response to the patent expiration of atypical antipsychotics in the State of Washington for fiscal year 2010." Pullman, Wash. : Washington State University, 2010. http://www.dissertations.wsu.edu/Thesis/Spring2010/C_Chandratre_042310.pdf.

Full text

Abstract:

Thesis (M.H.P.A.)--Washington State University, May 2010.<br>Title from PDF title page (viewed on July 20, 2010). "Department of Health Policy and Administration." Includes bibliographical references (p. 30-35).

APA, Harvard, Vancouver, ISO, and other styles

12

Karlsbakk, A. "Patents versus patients : global governance and the role of civil society in South Africa's quest for affordable drugs." Thesis, Stellenbosch : Stellenbosch University, 2005. http://hdl.handle.net/10019.1/50414.

Full text

Abstract:

Thesis (MA)--Stellenbosch University, 2005.<br>ENGLISH ABSTRACT: This thesis is an explanatory study into civil society's increased influence in global governance. More specifically this situation is examined by looking at the generic medicine debate that came in the wake of the passing of the Medicines and Related Substances Act by the South African government in 1997. This debate gained worldwide attention and touched some of the prevailing inequalities between the developed world and the developing world in our globalised society. The research question that is addressed here is to what

APA, Harvard, Vancouver, ISO, and other styles

13

Muhammad, Amran. "Patenting dyes and drugs in Britain, 1860-1960 : case studies on the role of patents in chemical science and industry." Thesis, University of Manchester, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557622.

Full text

Abstract:

A patent is a limited monopoly granted to an inventor by the state in return for the disclosure of new useful inventions. While the rights of patentees are protected and rewarded through royalties and licensing fees, for example, other enterprising bodies can develop new industries for the benefit of the public. Thus, the patent system has always been considered to be in a delicate position in serving both the rights of inventors and the interests of the public. However, in examining the relationship between scientists and the patent system in Britain between 1860 and 1960, it appears neither

APA, Harvard, Vancouver, ISO, and other styles

14

Babin, Dominique. "The Canadian pharmaceutical patent regime in the world trading system /." Thesis, McGill University, 1999. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=29957.

Full text

Abstract:

In 1994, the members of the World Trade Organisation (WTO) adopted the Agreement on Trade-Related Aspects of Intellectual Property (the "TRIPs Agreement") and thus committed themselves to respect certain standards for intellectual property protection. This thesis studies the scope of the standards for patent protection and their impact upon trade in medicines. The first part addresses the international dimension of the issue and explains how international trade in medicines can contribute to enhancing the level of global welfare. The first chapter argues that in order to fulfil this latter obj

APA, Harvard, Vancouver, ISO, and other styles

15

Albanese, Christopher J. "Estimating The Size Of The Pharmaceutical Patent Cliff." Scholarship @ Claremont, 2014. http://scholarship.claremont.edu/cmc_theses/854.

Full text

Abstract:

This paper attempts to estimate the change in sales associated with pharmaceutical patent expiration. Using data from the Medical Expenditure Panel Survey and patent expiration information from historical Orange Book publications, I estimated monthly sales associated with choice pharmaceutical patents. I then used a fixed-effects model to estimate the average change in sales before and after initial patent expiration, controlling for patent extension factors. My findings support that pharmaceutical patent expiration results in a statistically significant drop in sales by 38% on average within

APA, Harvard, Vancouver, ISO, and other styles

16

Momodu, Rametu Omamegbe. "Knowledge and practices of patent medicine vendors in the use of artemisinin based combination therapy in the treatment of malaria in an urban community in Lagos." Thesis, University of the Western Cape, 2008. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_2704_1271017667.

Full text

Abstract:

<p>Malaria is a health, social and economic burden in Nigeria and consistently ranks amongst the four most common causes of childhood deaths. Treatment of malaria is usually started at home<br>care is only sought from the health facility when the treatment is ineffective (McCombie, 1996). Patent medicine vendors (PMVs) have been identified as a widely patronized source for drugs used in the home treatment of malaria (Breiger et al, 2001<br>Goodman, et al, 2007<br>Salako et al, 2001). Inadequate or poor knowledge and practices in the use of anti-malaria drugs (AMDs) increases morbidity and mort

APA, Harvard, Vancouver, ISO, and other styles

17

Hoirisch, Cláudia. "Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz." reponame:Repositório Institucional do FGV, 2010. http://hdl.handle.net/10438/6559.

Full text

Abstract:

Submitted by Paulo Junior (paulo.jr@fgv.br) on 2010-05-13T21:02:37Z No. of bitstreams: 1 Cláudia Hoirisch.pdf: 1193444 bytes, checksum: 18921b0201a6008cb606c1dcc39797a0 (MD5)<br>Approved for entry into archive by Paulo Junior(paulo.jr@fgv.br) on 2010-05-13T21:03:02Z (GMT) No. of bitstreams: 1 Cláudia Hoirisch.pdf: 1193444 bytes, checksum: 18921b0201a6008cb606c1dcc39797a0 (MD5)<br>Made available in DSpace on 2010-05-14T12:29:32Z (GMT). No. of bitstreams: 1 Cláudia Hoirisch.pdf: 1193444 bytes, checksum: 18921b0201a6008cb606c1dcc39797a0 (MD5) Previous issue date: 2010-03-24<br>The scope of

APA, Harvard, Vancouver, ISO, and other styles

18

Abbas, Muhammad Zaheer. "Community-based patent opposition model in India: Access to medicines, right to health and sustainable development." Thesis, Queensland University of Technology, 2020. https://eprints.qut.edu.au/180843/1/Muhammad%20Zaheer_Abbas_Thesis.pdf.

Full text

Abstract:

Jeffrey Sachs' conceptions of enlightened globalization and directed technological change are relevant to patent law and access to medicines in India. This study was original in translating these concepts into a concrete and integrated package of patent law and policy reform proposals for India. This study presented new empirical data and undertook statistical analysis of India's patent opposition model. In light of Sachs' ideas, this project proposed a community-based patent opposition model as a novel solution complemented by other measures and policies like need-driven collaborative open in

APA, Harvard, Vancouver, ISO, and other styles

19

趙揚. "中國製藥企業的專利戰略 : 基於六家製藥企業的案例研究". Thesis, University of Macau, 2012. http://umaclib3.umac.mo/record=b2590327.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Basheer, Shamnad. "The invention of an investment incentive for pharmaceutical innovation." Thesis, University of Oxford, 2011. https://ora.ox.ac.uk/objects/uuid:b53d2ab0-dcdd-4adc-8728-cdf32e948df6.

Full text

Abstract:

Pharmaceutical drugs are often hailed as the poster child for the proposition that patents foster accelerated rates of innovation. This sentiment stems, in large part, from the significantly high research and development (R&D) costs endemic to the pharmaceutical sector. I argue that if the role of the patent regime is one of fostering higher amounts of investment in the R&D process, it is better served by a direct investment protection regime, where the protection does not depend upon whether or not the underlying idea behind the drug is 'new' and 'inventive', the two central tenets of patent

APA, Harvard, Vancouver, ISO, and other styles

21

Hedner, Erik. "Implementering av "Life Cycle Management" i svensk läkemedelsindustri." Thesis, University of Gävle, Department of Business Administration and Economics, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:hig:diva-5169.

Full text

Abstract:

<p>It generally takes 10 to 12 years for a new drug to hit the market. The pharmaceutical industry invests huge sums in these early stages of research and development. In spite of the rapidly rising research and development expenditures fewer and fewer blockbuster drugs are being developed. Longer lead times and aggressive generic post-patent competition have narrowed the timeframe for the pharmaceutical companies to profit on their investments.</p><p>In the face of these threats the pharmaceutical industry has developed a battery of strategies to prolong market exclusivity and to maximize ret

APA, Harvard, Vancouver, ISO, and other styles

22

Mbioh, Will Robinson. "Post-coloniality and the movements and readings of scientific and legal practices : the history of HIV/AIDS in Africa, patents, and the multilateral governance of generic drugs." Thesis, University of Kent, 2015. https://kar.kent.ac.uk/54170/.

Full text

Abstract:

This thesis examines the history, political economy, and global response to HIV/AIDS in Africa. It is particularly interested in how Africa’s colonial past and postcolonial struggles with European science and law influenced these issues. It therefore explores the many ways that the colonial encounter coloured how scientific knowledge about HIV/AIDS travelled to and was read and contested in Africa. In addition, it sets out how this encounter informed the political economy of debates about access to and the global governance of generic HIV/AIDS drugs in the continent. It draws on an interdiscip

APA, Harvard, Vancouver, ISO, and other styles

23

Djenna, Abdallah. "Brevet et développement : le cas de l'Algérie." Thesis, Grenoble, 2013. http://www.theses.fr/2013GREND004.

Full text

Abstract:

La logique du nouveau système économique international s'appuie sur l'idée que le brevet est un mécanisme juridique d'incitation à la recherche et au développement. L'objet de notre étude est de savoir si les écarts de niveau de développement entre les pays pouvaient avoir des effets sur la fonction du brevet dans les pays en voie de développement. Dans cette perspective, nous avons consacré la première partie de notre recherche à l'étude du droit des brevets sur le plan international. Cette analyse est indispensable pour une meilleure compréhension des choix opérés par un pays en développemen

APA, Harvard, Vancouver, ISO, and other styles

24

Loff, Beatrice. "Health and human rights : case studies in the potential contribution of a human rights framework to the analysis of health questions." Monash University, Dept. of Epidemiology and Preventive Medicine, 2004. http://arrow.monash.edu.au/hdl/1959.1/5291.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

高華. "中國制藥企業中的中成藥社會認同管理". Thesis, University of Macau, 2011. http://umaclib3.umac.mo/record=b2525100.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Loum-Neeser, N'deye fatou. "Les pays en développement et la brevetabilité des médicaments en matière de lutte contre le VIH/SIDA : étude de droit comparé sur les controverses actuelles concernant le rôle des brevets pharmaceutiques dans l'accès aux médicaments de traitement du VIH/SIDA des pays en voie de développement." Thesis, Strasbourg, 2012. http://www.theses.fr/2012STRAA034/document.

Full text

Abstract:

Dans les pays en développement (PED), les problèmes engendrés par le VIH/SIDA et l’inaccessibilité des antirétroviraux (ARV) s’avèrent être la cause de ravages extrêmement préoccupants à tous les niveaux (démographique, politique, social et économique). Dans le cadre de l’Organisation mondiale du commerce (OMC), et notamment de l’Accord sur les aspects des droits de propriété intellectuelle qui touchent au commerce (« Accord sur les ADPIC »), un nombre croissant de PED ont ou sont en train d’intégrer un standard international de protection des brevets de produits et de procédés pharmaceutiques

APA, Harvard, Vancouver, ISO, and other styles

27

Hsu, Lucy, and 徐秀珠. "Branded Drug Manufacturer Business Strategy in Taiwan – based on New and Post Patent Drugs of X Company." Thesis, 2016. http://ndltd.ncl.edu.tw/handle/ac9977.

Full text

Abstract:

碩士<br>國立政治大學<br>經營管理碩士學程(EMBA)<br>104<br>It is observed that the Taiwan health care environment, policies, payer’s attitude, tendency and patients’ expectations change over time and nothing has remained unchanged over the past years. To stay competitive over time, it is important to know what is learnt in the past and how to transform the learnings and make it be an aid in such a dynamic environment. This thesis focuses on how to maximize the product life cycle of a loss of exclusivity drug in Taiwan and how to leverage the time span between obtaining product license and gaining reimbursemen

APA, Harvard, Vancouver, ISO, and other styles

28

Volšanský, Petr. "Specifika patentového práva ve farmaceutickém průmyslu." Master's thesis, 2017. http://www.nusl.cz/ntk/nusl-266986.

Full text

Abstract:

1 ABSTRACT SPECIFIC OF PATENT LAW IN PHARMACEUTICAL INDUSTRY This thesis scopes on particularities of patent law with regard to pharmaceuticals. It describes the basics of patent law while focusing mainly on international treaties, in particular on systems established by EPC and TRIPS. The patent system in USA and in the Czech Republic is also noted. This thesis is divided into seven chapters. In the first chapter named sources of law international institutions, treaties and situation in European union, USA and Czech Republic are described here. This chapter also deals with basic legal instrum

APA, Harvard, Vancouver, ISO, and other styles

29

Keele, Mothobi Godfrey. "Beyond patent expiry: development of a model for pricing generic drugs in South Africa." Thesis, 2017. https://hdl.handle.net/10539/25605.

Full text

Abstract:

A thesis submitted to the Faculty of Health Sciences, University of the Witwatersrand, in fulfilment of the requirements for the degree of Doctor of Philosophy. Johannesburg, 2017.<br>Background: Generic drugs provide a safe, effective and affordable alternative to medicines whose patent protection has expired. The affordability of generics improves access to medicines and thus improves health outcomes. The generic pharmaceutical industry is complex; profitability depends on the number of other generics on the market. Objective: To develop a model that explains structural relationships in

APA, Harvard, Vancouver, ISO, and other styles

30

Bourassa, Forcier Mélanie. "Analyse des glissements juridiques de la politique canadienne en matière de brevets quant à son objectif d'équilibre entre la promotion des intérêts de l'industrie pharmaceutique novatrice et ceux de l'industrie du médicament générique." Thèse, 2003. http://hdl.handle.net/1866/2389.

Full text

Abstract:

Les provinces canadiennes sont présentement aux prises avec des dépenses élevées en matière de médicaments. Afin de contrôler ces dépenses, plusieurs d'entre elles ont adopté différentes politiques visant à promouvoir et à accélérer la vente de médicaments génériques, lesquels sont équivalents aux médicaments novateurs mais de trente à quarante pourcents moins chers. Le gouvernement canadien, en vertu de son pouvoir de réglementation en matière de brevets, pourrait contribuer aux efforts des gouvernements provinciaux en assouplissant les règles relatives aux brevets pharmaceutiques pour ainsi

APA, Harvard, Vancouver, ISO, and other styles

31

Collins, Robert J. "Technology and public policy : patent protection for new drugs in Canada." Thesis, 1989. http://spectrum.library.concordia.ca/10/1/ML49084.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Jhen-Hong, Yang, and 楊鎮鴻. "The Impact of US Patent Linkage on Marketing of Generic Drugs." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/10912532232187830025.

Full text

Abstract:

碩士<br>國立雲林科技大學<br>科技法律研究所<br>103<br>Patent linkage system involves linking generic drug marketing approval with the originator drug’s patent status and refusing marketing approval until the relevant patent expires. However, generic pharmaceutical marketing as main market in Taiwan, and there is no patent linkage system in Taiwan, so there are still doubts about bringing in patent linkage system. For solve these question, first we discuss the legislative history and Current status of patent linkage system in US and the regulation of Biomedical and pharmaceutical in Taiwan. And then we discuss t

APA, Harvard, Vancouver, ISO, and other styles

33

Chen, Huang-Yu, and 陳皇宇. "Demand Forecasting for the Patent Expiration Drug." Thesis, 2019. http://ndltd.ncl.edu.tw/handle/n257q8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Liu, Ying-Hsiu, and 劉英秀. "Observing the Pharmaceutical Patents' Development and Portfolio of International Pharmaceutical Company by Patent Analysis - a Case Study of Anti-HER2 Targeted Drugs for Breast Cancer." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/jf5ue7.

Full text

Abstract:

碩士<br>國立臺灣科技大學<br>專利研究所<br>103<br>New drug research and innovation is a high-risk investment in the field of medicine, it has some characteristics, such as from R&D to launch a new drug to market is a time-consuming process and pharmaceutical companies still invest the great cost of capital during this period, pharmaceutical companies in order to improve cost recovery and return on investment, most of all will seek patent right to protect their products. The patent law offers the exclusive right to the inventors in a limited period of time, in this reason, brand name pharmaceutical companies c

APA, Harvard, Vancouver, ISO, and other styles

35

Wu, Tung-Che, and 吳東哲. "Pre-Approval Patent Resolution Process of Drug Product－ Lessons From U.S. Patent Linkage." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/2bx5ms.

Full text

Abstract:

碩士<br>國立政治大學<br>法律科際整合研究所<br>104<br>As the phamaceutical industry’s market leader, the United States continues to call for strengthening patent protection for pharmaceutical products during every trade negotiation, to preserve its national profit and leadership. Taiwan, being highly interested in joining “Trans-Pacific Partnership Agreement” (TPP) and signing “Trade and Investment Framework Agreement” (TIFA) with the United States, Taiwan's government is actively promoting the “patent linkage” since 2014. Althougn the effort done by Taiwan's government is extremely welcomed by American Chamber

APA, Harvard, Vancouver, ISO, and other styles

36

Hubálková, Pavla. "Competitive intelligence ve farmaceutickém průmyslu." Master's thesis, 2016. http://www.nusl.cz/ntk/nusl-350502.

Full text

Abstract:

This diploma thesis describes and analyzes an area of competitive intelligence in the pharmaceutical industry. The work is divided into five parts. The first part deals with competitive intelligence and related aspects, the second part is dedicated to the pharmaceutical industry, with all specifics. The third part deals with competitive intelligence in the intersection with the pharmaceutical industry, the fourth part contains the classification and description of information resources appropriate for the activities of CI and a fifth part presents research, which consists of a questionnaire s

APA, Harvard, Vancouver, ISO, and other styles

37

Chang, Teng-Feng, and 張登封. "The patent searching analysis and products planning - The empirical study of anticancer drugs." Thesis, 2003. http://ndltd.ncl.edu.tw/handle/06888847260752845636.

Full text

Abstract:

碩士<br>國立東華大學<br>國際企業研究所<br>91<br>In order to develop product strategy for anticancer drugs of liver cancer technology, the study uses patent analysis, software Patent Guider 1.0, to analyze product anticancer drugs — thalidomide and adrianycin through USPTO patent searching. The results indicated that the thalidomide and adriamycin were in the product decline stage. According to Industry Life Cycle Theory, an enterprise should adapt the transformation strategy. For managerial implication, an enterprise in Taiwan should adapt the technology-licensing to exploit emerging market. Due to, these tw

APA, Harvard, Vancouver, ISO, and other styles

38

Santos, Letícia. "Patente farmacêutica e medicamento genérico: o risco de conflito entre o interesse privado e o interesse público." Master's thesis, 2019. http://hdl.handle.net/1822/71863.

Full text

Abstract:

Dissertação de mestrado em Direito dos Contratos e da Empresa<br>O acesso ao medicamento é pilar fundamental do direito à saúde amparado pelas legislações nacionais e pelas normas do direito internacional. Inúmeros são os desafios para a garantia desse direito à sociedade, pois o setor farmacêutico é complexo e apresenta especificidades de ordem jurídica, econômica e social. Neste trabalho, sob a perspectiva do Direito da Propriedade Industrial, com foco nas patentes farmacêuticas em contraponto à livre comercialização dos medicamentos genéricos, analisamos o risco de conflito entre o in

APA, Harvard, Vancouver, ISO, and other styles

39

TSAI, HSIN-PEI, and 蔡欣貝. "The Impact on Patent Linkage of Pharmaceutical Industry and Access of Drugs in Taiwan." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/hy87u4.

Full text

Abstract:

碩士<br>逢甲大學<br>財經法律研究所<br>106<br>Patent linkage is the system, which a competent authority adapt to the patent status of the originator product during the sale of generic drugs review process. Patent linkage is a common policy for government to manage the drug market. Besides safeguarding pa-tent rights, it provides invention incentives to achieve the goal of promoting economic growth. In early years, there was a debate while establishing patent linkage system in Tai-wan. Recently, in order to coordinate U.S. policy and join the TPP and TIFA, the Ex-ecutive Yuan proposed a draft amendment

APA, Harvard, Vancouver, ISO, and other styles

40

Huang, Yu-Chun, and 黃鈺鈞. "The Application and the Challenge of the Pharmaceutical Drugs Patent Linkage System in Taiwan." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/4k4tb9.

Full text

Abstract:

碩士<br>國立臺灣科技大學<br>專利研究所<br>106<br>In recent years, in order to cooperate with the Free Trade Agreement (FTA), the Executive Yuan of Taiwan has announced the Pharmaceutical Affairs Law’s latest amendment and declared to establish the patent linkage system in 2016. The partial amendment of Pharmaceutical Affairs Law legislated on Dec. 29th, 2017 indicates that patent linkage system was established to strengthen the relation between the listed drugs and the disclosure of the patent information, so as to let the original branded drug companies and the generic drug companies to clarify the potentia

APA, Harvard, Vancouver, ISO, and other styles

41

WENG, SHENG-CHIEH, and 翁聖杰. "A Study on Patent Litigation Strategies of Generic Drug Company." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/80622061114950821229.

Full text

Abstract:

碩士<br>東吳大學<br>法律學系<br>102<br>The pharmaceutical expenditures have been increasing due to the use of patented new drugs and have caused heavy financial burdens for worldwide governments. Therefore, in recent years, to support the low-cost generics for saving health care expenditures has become the direction of pharmaceutical policies for worldwide governments. In 2009 the patented drugs market facing the competition from generics already reaches 24 billion US dollars. These generics competitors developed price war in each therapeutic category and diminished the profits of pharmaceutical compani

APA, Harvard, Vancouver, ISO, and other styles

42

Huang, Chiu-jung, and 黃秋蓉. "The Patent Linkage Program of the U.S Drug Market Review." Thesis, 2013. http://ndltd.ncl.edu.tw/handle/98198773946196491541.

Full text

Abstract:

碩士<br>國立雲林科技大學<br>科技法律研究所碩士班<br>101<br>The patent linkage program of the United States, means that the marketing approval of generic drugs are 「linked」to the judgment of whether the generics infringe a valid patent held by a brand-name pharmaceutical company on the same type of drugs or not. In the drug for market, most high-profit drugs protected by patents, inexpensive generic drugs have the opportunity to enter the U.S. market in the patent expires. In 1984 through the 「Drug Price Competition and Patent Compensation Act」, Also known as the Hatch Waxman Act, jurisdiction by the U.S. Federal

APA, Harvard, Vancouver, ISO, and other styles

43

Chien, Ting-Feng, and 簡庭鳳. "The Patent Analysis Studies of the Technology Strategy for Anticancer Drug." Thesis, 2002. http://ndltd.ncl.edu.tw/handle/62928187463821057670.

Full text

Abstract:

碩士<br>國立東華大學<br>國際企業研究所<br>90<br>Through patent analysis technique, we explored the trend of the anticancer technology development in this study. We analyzed Taxol relevant patents by patent Guider 1.0 and American patent database USPTO. Also, several major Taxol patents-own companies were chosen for comparing their development trend. The patent analysis included technology life cycle analysis, patent citation, and the patent of the generic technology. The most of the anticancer patents are organic chemistry invention, and that are significantly progressing. Taiwan pharmaceutical manufactures

APA, Harvard, Vancouver, ISO, and other styles

44

Hsiao, Fei-Chen. "A Discussion of Patent Protection of Pharmaceutical Drugs and Plant Varieties under a Bilateral Investment Treaty." 2004. http://www.cetd.com.tw/ec/thesisdetail.aspx?etdun=U0001-2207200406523900.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hsiao, Fei-Chen, and 蕭斐甄. "A Discussion of Patent Protection of Pharmaceutical Drugs and Plant Varieties under a Bilateral Investment Treaty." Thesis, 2004. http://ndltd.ncl.edu.tw/handle/76912025786426519155.

Full text

Abstract:

碩士<br>國立臺灣大學<br>法律學研究所<br>92<br>“Most [bilateral investment treaties] are between developed and developing countries, with Europe and Asia having signed the largest share. But a full quarter are now brokered between developing countries themselves. In essence, these deals set up rules for the entry, protection and exit of investments between two countries – and ‘investment’ in these treaties specifically includes intellectual property. Parties are expected to open their borders to foreign investments, provide the ‘highest international standards’ of [IPRs] protection for them in their domesti

APA, Harvard, Vancouver, ISO, and other styles

46

Cheng, Kuei-Hung, and 鄭貴虹. "A Comparative Study of Experimental Use Exception to Patent Infringement-- Taken Generic Drugs as an Example--." Thesis, 2010. http://ndltd.ncl.edu.tw/handle/15228654560355530031.

Full text

Abstract:

碩士<br>東吳大學<br>法律學系<br>98<br>Abstract The drugs, which matter human health and the disease prevention, has a unique relation with public health. The original purpose of the patent law is to offer the exclusive right to the inventors in a limited period of time. A patentee enjoys the exclusive right to prohibit anyone to make, use, offer to sell, or sell any patented inventions without the authorization from the patentee, within the countries, or import into the countries. The ultimate purpose of the patent law is to encourage innovations. Because the patents of drugs expire one after another, t

APA, Harvard, Vancouver, ISO, and other styles

47

Barron, Paul. "Management decisions regarding end patent strategies in the South African private pharmaceutical market." Diss., 2013. http://hdl.handle.net/2263/41894.

Full text

Abstract:

The loss of patent protection for a pharmaceutical product is a significant event for manufacturers. Although this phenomenon has been occurring in the industry for decades, it has been of increased interest during the past few years due to the much publicised “patent cliff” experienced by a number of major pharmaceutical manufacturers. Recent developments in emerging economies such as India and South Africa have brought the concept of intellectual property rights under review. The traditional approach to extend market exclusivity through the use of secondary patents is no longer valid. New pr

APA, Harvard, Vancouver, ISO, and other styles

48

Trigo, Joana Horta Ferreira. "Patentes de segundo uso médico : o problema do cross label use." Master's thesis, 2018. http://hdl.handle.net/10400.14/26760.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Bartkowski, Janina Magdalena. "The patent expiry as a major inflection point in a branded Rx drug's life and strategies to counter generic competition - exemplified at Pfizer's blockbuster drug Lipitor in the USA." Master's thesis, 2014. http://hdl.handle.net/10362/15047.

Full text

Abstract:

A large number of expensive, but highly profitable branded prescription drugs will go off-patent in the USA between 2011 and 2015. Their revenues are crucial to fund the immense costs associated with the development of an innovative drug. The rising cost pressure on pharmaceutical stakeholders has increased the demand for more affordable medications, as provided by the branded drug's generic counterpart. Yet, research based incumbents are moving beyond the traditional late lifecycle strategies and deploy more aggressive tactics in order to protect their brands, as seen with Pfizer's Lipitor!.

APA, Harvard, Vancouver, ISO, and other styles

50

Cheng, Sheng-Yu, and 鄭聖諭. "Analysis of patent portfolio in the United States - Case study of Gilead Sciences, Inc. in Hepatitis C Drugs." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/ap45ys.

Full text

Abstract:

碩士<br>國立政治大學<br>科技管理與智慧財產研究所<br>106<br>This study mainly explored the patent portfolio strategy of Gilead Sciences, Inc. (Gilead) in the United States regarding HCV, and conducted in-depth research on the actual patent-related practices of Gilead in a case-study manner, and suggested how Taiwanese pharmaceutical companies could conduct patent portfolio under United States patent system for self-protection. From 2011 to 2017, there were 6 pharmaceutical companies involved in the market of HCV drugs, and 11 new HCV drugs were launched, 4 of which were owned by Gilead. There were 693 patents owne

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!